The Hope Institute Treatment Center

What The Hope Institute Treatment Center does

The Hope Institute Treatment Center is a private outpatient addiction treatment facility headquartered at 179 Cahill Cross Road in West Milford, New Jersey, serving adults with substance use disorders across Northern New Jersey (Passaic, Morris, Sussex, and Bergen counties) with telehealth extending reach further. Founded in 2022 and operating with approximately 16 employees, the center delivers evidence-based outpatient care through a stepped continuum — Partial Care (PHP), Intensive Outpatient (IOP), Outpatient (OP), 12-Step integration, and Aftercare — anchored by Medication-Assisted Treatment using buprenorphine and naltrexone and combined with Cognitive Behavioral Therapy, group therapy, individual therapy, and dual diagnosis care for co-occurring mental health conditions.

The clinical platform is built around specialized protocols for alcohol, cocaine, heroin, prescription drug (opioid, benzodiazepine, stimulant), and methamphetamine use disorders, and is medically overseen by an ASAM-affiliated physician. Service delivery is conducted in person at the West Milford facility and via telehealth, supported by a 24/7 admissions helpline and free insurance verification. The center is accredited by The Joint Commission for behavioral health care and carries a Trustindex-verified EXCELLENT rating based on 140 Google reviews.

Revenue is generated by billing outpatient treatment services and MAT to a diversified panel of commercial insurance carriers including Horizon Blue Cross Blue Shield of New Jersey, UnitedHealthcare, Aetna, Cigna, Humana, AmeriHealth, Oscar, Molina, Highmark, and others, with private-pay as a fallback. Go-to-market is inbound-driven: prospective patients enter via the 24/7 phone line, online contact forms, insurance verification, and SEO-optimized content marketing addressing addiction and withdrawal topics. The organization appears to be privately held and founder/operator-managed with no disclosed institutional investors or external funding.

Name

The Hope Institute Treatment Center

Legal name

The Hope Institute

Website

https://thehopeinstitutenj.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

The Hope Institute Treatment Center is a private, Joint Commission–accredited outpatient addiction treatment facility in West Milford, New Jersey, serving adults with substance use disorders across Northern New Jersey through MAT, CBT, dual diagnosis care, and telehealth across PHP, IOP, OP, and aftercare levels.

Ownership category

akta.pro rank

Product category

Outpatient Addiction Treatment Services

NAICS

Outpatient Mental Health and Substance Abuse Centers (621420), Outpatient Mental Health and Substance Abuse Centers (62142), Offices of Mental Health Practitioners (except Physicians) (621330)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Health Services (8000)

akta.pro primary industry

Outpatient Substance Use Treatment Programs (IOP/PHP/OP) (HLAFACAF)

akta.pro secondary industry

Outpatient Substance Use Disorder (SUD) Treatment Programs (HLAFABAD)

Keywords

• Outpatient addiction treatment
• Medication-assisted treatment
• Drug alcohol rehab
• Intensive outpatient program
• Dual diagnosis treatment

Headquarters

HQ city

West Milford

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Outpatient Treatment Services: Revenue generated from outpatient addiction treatment programs including Partial Care (PHP), Intensive Outpatient (IOP), and standard Outpatient (OP) levels. Treatment is billed to insurance or paid privately, with most major insurance plans accepted including Horizon Blue Cross Blue Shield, AmeriHealth, Aetna, UnitedHealthcare, Cigna, Humana, and others.
2. Medication-Assisted Treatment: Ongoing MAT services combining FDA-approved medications with counseling. Treatment typically runs at least one year with billing aligned to insurance coverage for medication and counseling sessions.
3. Insurance Verification and Benefits Management: The center verifies insurance benefits before treatment begins, working with major commercial insurance plans to confirm coverage and explain out-of-pocket costs.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

The Hope Institute Treatment Center provides outpatient drug and alcohol addiction treatment for adults, delivered through a stepped-care model spanning Partial Care (PHP), Intensive Outpatient (IOP), Outpatient (OP), and Aftercare programs. Treatment is anchored by FDA-approved Medication-Assisted Treatment (buprenorphine and naltrexone), Cognitive Behavioral Therapy, individual and group counseling, and dual diagnosis care for co-occurring mental health conditions. The center also provides professional drug and alcohol intervention services for families, with both in-person care at its West Milford, NJ facility and telehealth options.

Product overview

The Hope Institute Treatment Center is a substance abuse treatment facility offering outpatient addiction recovery programs in West Milford, New Jersey. The company operates a unified treatment platform with multiple levels of care and therapeutic modalities. The core offerings include specialized addiction treatment programs for alcohol, cocaine, heroin, prescription drugs, and meth, delivered through a stepped-care model: Partial Care (PHP), Intensive Outpatient (IOP), Outpatient (OP), and Aftercare. Treatment is anchored by Medication-Assisted Treatment (MAT) using buprenorphine and naltrexone, combined with cognitive behavioral therapy, group therapy, individual therapy, and dual diagnosis care. The center also provides professional intervention services to support families in crisis. All programs are outpatient-based, allowing clients to live at home while receiving structured treatment.

Differentiator

Problem solved

Functional benefit

Products and services

• Medication-Assisted Treatment (MAT) Outpatient program combining FDA-approved medications (buprenorphine/Suboxone and naltrexone/Vivitrol) with counseling and behavioral therapy to treat opioid and alcohol addiction on an outpatient basis.
• Alcohol Addiction Treatment Outpatient program for adults recovering from alcohol use disorder combining medication-assisted treatment (naltrexone) with cognitive behavioral therapy, individual counseling, and group therapy.
• Heroin Addiction Treatment Outpatient program combining medication-assisted treatment (buprenorphine and naltrexone) with cognitive behavioral therapy and counseling for adults recovering from heroin and opioid addiction.
• Prescription Drug Addiction Treatment Outpatient program treating dependence on opioids, benzodiazepines, and stimulants using medication-assisted treatment for opioids, medically supervised taper for benzodiazepines, and behavioral therapy for stimulants.
• Cocaine Addiction Treatment Outpatient program for stimulant use disorder using behavioral therapy including cognitive behavioral therapy and contingency management across partial care, intensive outpatient, and outpatient levels.
• Meth Addiction Treatment Outpatient program for stimulant use disorder using behavioral therapy including contingency management and cognitive behavioral therapy across partial care, intensive outpatient, and outpatient levels.
• Cognitive Behavioral Therapy (CBT) Evidence-based therapeutic approach helping individuals manage triggers, cravings, and thought patterns that drive addiction through skill-building and behavioral modification.
• Individual Therapy One-on-one counseling sessions providing personalized therapeutic support addressing individual addiction patterns, triggers, and recovery goals.
• Group Therapy Therapeutic sessions conducted in collaborative group settings that enable individuals to understand addiction and recovery while building peer accountability and support.
• Dual Diagnosis Treatment Integrated treatment addressing co-occurring substance use disorders and mental health conditions such as depression, anxiety, and trauma in a unified treatment plan.
• Partial Care Program (PHP) Most structured outpatient level offering daytime treatment for individuals requiring intensive support while returning home each evening.
• Intensive Outpatient Program (IOP) Structured outpatient program with several clinical sessions per week built around work, school, or family commitments.
• Outpatient Program (OP) Ongoing counseling at a lighter weekly schedule for individuals whose recovery has stabilized.
• 12-Step Program Recovery support program incorporating 12-step Principles of Recovery into the treatment continuum.
• Aftercare Program Continued groups and planning support after structured treatment ends, including 12-step support and alumni services.
• Drug and Alcohol Intervention Services Professional intervention services to help families initiate the recovery process for loved ones struggling with drug or alcohol addiction.
• Telehealth Addiction Treatment Remote counseling and therapy sessions delivered via telehealth platform, expanding treatment access to patients across Northern New Jersey who cannot travel to the West Milford facility.

Quantifiable outcome

• 140 verified customer reviews with EXCELLENT rating (Trustindex verified)

Named customers5 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Insurance Providers (Various)coreChannel Partner/ Reseller/ DistributorThe Hope Institute participates as an in-network provider with most major commercial insurance plans including Horizon Blue Cross Blue Shield of New Jersey, AmeriHealth, Oscar Health, Humana, Ameritas, Aetna CVS Health, UnitedHealthcare, Cigna Health, Molina Healthcare, Highmark Group, Blue Cross Blue Shield, CareSource, UPMC Health System, CareFirst Inc., Metropolitan, Point32Health Inc., Health Net, and others. Insurance verification is provided free of charge before treatment begins.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Summit Behavioral Health: Multi-location outpatient and residential addiction treatment provider with PHP, IOP, OP, and MAT programs. Comparable in clinical model and patient segment, though operating at significantly greater scale and geographic reach.
• Princeton Detox & Recovery Center: New Jersey addiction treatment provider offering outpatient and partial care programs alongside detox services. Comparable to Hope on regional market and outpatient SUD treatment focus.
• New Hope Recovery Center: Outpatient addiction treatment provider in the Northeast offering IOP, OP, MAT, and co-occurring disorder services. Comparable to Hope on outpatient-only delivery, clinical model, and patient demographic.
• Turning Point of New Jersey: Outpatient substance use and behavioral health treatment provider serving New Jersey with multiple levels of care, including IOP and OP. Most directly comparable to Hope on geography, outpatient-only model, and target patient population.
• Enlightened Solutions: New Jersey-based outpatient addiction and mental health treatment center offering IOP, OP, MAT, and dual diagnosis care. Closely comparable to Hope in service mix, regional scope, and outpatient-only delivery model.

Broad incumbents

• American Addiction Centers: Publicly traded national network of residential and outpatient substance abuse treatment facilities. Comparable on outpatient SUD treatment model, MAT, and insurance contracting, but operates at vastly larger scale.
• Caron Treatment Centers: Well-established Pennsylvania-headquartered addiction treatment provider with residential and outpatient programs serving the Mid-Atlantic, including New Jersey referrals. Comparable on clinical approach and patient population but at significantly greater scale and brand recognition.
• Banyan Treatment Centers: Multi-state addiction treatment provider offering PHP, IOP, OP, MAT, and dual diagnosis programming. Comparable in clinical model and treatment continuum but at larger, multi-state scale.
• Recovery Centers of America: Northeast-based chain of residential and outpatient addiction treatment facilities, including several New Jersey sites. Comparable on outpatient SUD treatment but operates at substantially larger scale with broader service portfolio.
• Hazelden Betty Ford Foundation: National nonprofit addiction treatment leader with extensive outpatient programming including IOP, OP, MAT, and aftercare. Comparable on evidence-based outpatient SUD offerings and reputation-driven demand, though at much greater scale and geographic reach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/thehopeinstitutenj
• Instagraminstagram.com/thehopeinstitutenj
• LinkedInlinkedin.com/company/the-hope-institute-treatment-center

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Hope Institute Treatment Center